Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026)
Opko Health's (OPK) quarterly Total Non-Current Liabilities came in at $495.9 million in Q2 2026, down 1.78% YoY from $504.9 million in Q2 2025, and down 1.56% on a QoQ basis from $503.8 million in Q1 2026.
Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Total Non-Current Liabilities data on file, last reported at $495.9 million in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 1.78% year-over-year to $495.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $495.9 million (down 1.78% YoY) and the FY2025 annual result came in at $517.3 million, down 19.38% from the prior year.
- Total Non-Current Liabilities declined to $495.9 million in Q2 2026, from $503.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $641.7 million in Q4 2024 to a low of $328.4 million in Q3 2022.
- A 5-year average of $466.3 million and a median of $465.6 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities surged 55.76% — and 2025, when it dropped 19.38%.
- Tracing OPK's Total Non-Current Liabilities over 5 years: stood at $392.1 million in 2022, then climbed by 7.73% to $422.4 million in 2023, then jumped by 51.9% to $641.7 million in 2024, then declined by 19.38% to $517.3 million in 2025, then decreased by 4.13% to $495.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $495.9 million (Q2 2026), $503.8 million (Q1 2026), and $517.3 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Opko Health | 1.02 Bn | 718.85 Mn | 80.02 Mn | 495.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 495.92 Mn |
| Mar 31, 2026 | 503.80 Mn |
| Dec 31, 2025 | 517.31 Mn |
| Sep 30, 2025 | 520.70 Mn |
| Jun 30, 2025 | 504.90 Mn |
| Mar 31, 2025 | 520.81 Mn |
| Dec 31, 2024 | 641.67 Mn |
| Sep 30, 2024 | 641.03 Mn |
| Jun 30, 2024 | 365.00 Mn |
| Mar 31, 2024 | 516.87 Mn |
| Dec 31, 2023 | 422.43 Mn |
| Sep 30, 2023 | 411.56 Mn |
| Jun 30, 2023 | 397.10 Mn |
| Mar 31, 2023 | 395.44 Mn |
| Dec 31, 2022 | 392.13 Mn |
| Sep 30, 2022 | 328.45 Mn |
| Jun 30, 2022 | 435.33 Mn |
| Mar 31, 2022 | 382.80 Mn |
| Dec 31, 2021 | 384.58 Mn |
| Sep 30, 2021 | 369.04 Mn |